Cargando…

Evaluation of DNA damage in tobacco associated human buccal cells using comet assay

AIM AND OBJECTIVE: To assess the DNA damage in tobacco associated human buccal cells using comet assay. METHODS: The study included 75 study subjects, which were divided into 3 groups on the basis of tobacco usage. Group I - 25 individuals with no history of tobacco usage, Group II - 25 individuals...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohanapriya, Shanmugam, Maheswaran, Thangadurai, Ganapathy, Nalliapan, Yoithapprabhunath, Thukanayakanpalayam Ragunathan, Dineshshankar, Janardhanam, Ilayaraja, Vadivel, Vinodhini, Rachel Sarah, Devi, Renuga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118208/
https://www.ncbi.nlm.nih.gov/pubmed/34013193
http://dx.doi.org/10.15386/mpr-1692
Descripción
Sumario:AIM AND OBJECTIVE: To assess the DNA damage in tobacco associated human buccal cells using comet assay. METHODS: The study included 75 study subjects, which were divided into 3 groups on the basis of tobacco usage. Group I - 25 individuals with no history of tobacco usage, Group II - 25 individuals with tobacco usage but without oral lesions and Group III - 25 individuals with tobacco associated oral lesions. Cytological smears collected from these individuals were used to assess the tobacco associated DNA damage by measuring the tail length in the comet assay method. RESULTS: The average tail length was found to be 1.46 μm in the normal mucosa, 2.86 μm in tobacco users without oral lesions, 3.86 μm in the lesional sites of tobacco users and 3.67 μm in the non-lesional sites of these individuals. Factors like age, gender, duration and different forms of tobacco habit had their own impact on the oral mucosa. CONCLUSION: Comet assay helps assess the subclinical genetic changes of oral mucosa even before the clinical manifestations of the precancerous lesions appeared due to tobacco usage. Thus, comet assay may bloom out as a novel adjuvant tool for the prevention of oral cancer in the near future.